CLRB: Cellectar Biosciences, Inc. Stock

by  •  • Comments Off on CLRB: Cellectar Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 56.64
Enterprise Value ($M) 37.38
Book Value ($M) 16.55
Book Value / Share 0.46
Price / Book 3.42
NCAV ($M) 15.15
NCAV / Share 0.42
Price / NCAV 3.74

Profitability (mra)
Return on Invested Capital (ROIC) -2.94
Return on Assets (ROA) -2.33
Return on Equity (ROE) -10.97

Liquidity (mrq)
Quick Ratio 1.77
Current Ratio 1.77

Balance Sheet (mrq) ($M)
Current Assets 35.90
Assets 37.29
Liabilities 20.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Lytton Laurence W 9.99 33.83
11-14 13G/A ADAR1 Capital Management, LLC 8.51
08-14 13G/A Rosalind Advisors, Inc. 9.90 35.51
02-14 13G/A Lincoln Park Capital Fund, LLC 9.68 39.41
02-14 13G Nantahala Capital Management, LLC 9.90
02-07 13G/A Hirschman Orin 8.70 39.01
01-31 13G ADAR1 Partners, LP 6.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-18 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-10-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2
2024-10-29 10-Q/A U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-29 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 205,183 525,154 39.07
2024-11-21 301,136 1,342,114 22.44
2024-11-20 118,948 736,968 16.14
2024-11-19 640,173 1,746,864 36.65

(click for more detail)

Similar Companies
CKPT – Checkpoint Therapeutics, Inc. CLDX – Celldex Therapeutics, Inc.
CLNN – Clene Inc. CMPX – Compass Therapeutics, Inc.
CNSP – CNS Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io